Human Pegivirus Type 1 Coinfections: Epidemiology, Heterogeneity and Clinical Implications
Journal of General Virology · 05.11.2026 · 107 (11)
DOI: 10.1099/jgv.0.002365 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of General Virology, erschienen am 05.11.2026. Verfasst von Mathieu Garand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Coinfection, Flaviviridae Infections, GB virus C, Pegivirus. Die Arbeit nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, SLCH Research Foundation, U.S. Department of Veterans Affairs.
Abstract (Originalsprache)
This narrative review explores the complex landscape of coinfections involving Human Pegivirus Type 1 (HPgV), a member of the Hepaciviridae family previously known as GB virus type C or hepatitis G virus. Structurally similar to hepatitis C virus (HCV), HPgV is lymphotropic and while viraemia in healthy donors is asymptomatic, it has been associated with the onset of several non-Hodgkin lymphoma subtypes. We begin with an overview of HPgV’s genomic features, classification, transmission routes and natural history, including spontaneous clearance and post-infection anti-E2 antibody development. As of 03 February 2026, a PubMed search yielded 346 relevant studies from which data were synthesized, reporting HPgV coinfection across human immunodeficiency virus (HIV), HCV, hepatitis B virus and other viral diseases – highlighting genotype distributions, geographic variability and population-specific patterns. In summary, HPgV shows a reproducible signal in HIV coinfections, suggesting potential therapeutic benefits, while its impact on chronic hepatitis, acute infections and lymphoma risk remains preliminary and requires further investigation. This review highlights the need for rigorous prospective studies with standardized protocols to clarify HPgV’s true impact on human health and its potential for therapeutic application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Infectious Diseases, Departments of Internal Medicine, Microbiology and Immunology, University of Iowa and the Iowa City Veterans Administration Medical Center, Iowa City, USA.
Förderung
- BLRD VA
- SLCH Research Foundation
- U.S. Department of Veterans Affairs
- VA SecCURE
Zitieren
APA
Garand, M., Zhang, C. C., Guo, G., Zhong, T., Stapleton, J. T., & Eghtesady, P. (2026). Human Pegivirus Type 1 Coinfections: Epidemiology, Heterogeneity and Clinical Implications. Journal of General Virology, 107(11). https://doi.org/10.1099/jgv.0.002365
Vancouver
Garand M, Zhang CC, Guo G, Zhong T, Stapleton JT, Eghtesady P. Human Pegivirus Type 1 Coinfections: Epidemiology, Heterogeneity and Clinical Implications. Journal of General Virology. 2026;107(11). doi:10.1099/jgv.0.002365
BibTeX
@article{Garand2026,
author = {Garand, Mathieu and Zhang, Ching Ching and Guo, Grace and Zhong, Ting and Stapleton, Jack T and Eghtesady, Pirooz},
title = {Human Pegivirus Type 1 Coinfections: Epidemiology, Heterogeneity and Clinical Implications},
journal = {Journal of General Virology},
year = {2026},
volume = {107},
number = {11},
doi = {10.1099/jgv.0.002365}
}
EUVIMED